Melanoma de coroide

De ceos
Revisão de 18h09min de 16 de novembro de 2023 por Autor (Discussão | contribs) (Criou página com ' ==Referências:== 1. American Academy of Ophthalmology. Choroidal melanoma. https://www.aao.org/image/choroidal melanoma-4 Accessed June 28, 2019. 2....')
(dif) ← Edição anterior | Revisão atual (dif) | Versão posterior → (dif)
Ir para: navegação, pesquisa




Referências:

      1. American Academy of Ophthalmology. Choroidal melanoma. https://www.aao.org/image/choroidal melanoma-4 Accessed June 28, 2019.
      2.  -- Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011 Sep;118(9):1881-5.
      3. Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012 Jul;32(7):1363-72.
      4.  Nayman T, Bostan C, Logan P, Burnier MN Jr. Uveal Melanoma Risk Factors: A Systematic Review of Meta-Analyses. Curr Eye Res. 2017 Aug;42(8):1085-1093. doi: 10.1080/02713683.2017.1297997. Epub 2017 May 11. PMID: 28494168. 
      5. Ezekiel Weis, MD, MPH, Chirag P. Shah, MD, MPH, Martin Lajous, MD, Jerry A. Shields, MD, Carol L. Shields, MD. The Association Between Host Susceptibility Factors and Uveal Melanoma: A Meta-analysis. Arch Ophthalmol. 2006;124(1):54-60. 
      6.Johanna M. Seddon, MD; Evangelos S. Gragoudas, MD; Robert J. Glynn, ScD; Kathleen M. Egan, MPH; Daniel M. Albert, MD; Peter H. Blitzer, MD. Host Factors, UV Radiation, and Risk of Uveal Melanoma. Arch Ophthalmol. 1990;108(9):1274-1280. 
      7. Smith J.H., Padnick-Silver L., Newlin A.,et al. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Ophthalmology 2007; 114: 774-779
      8.  Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005 Oct;112(10):1784-9.
      9. Walpole S, Pritchard AL, Cebulla CM et al. Comprehensive study of the clincial phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst 2018;110:1328-41
      10.  Derrien A, Rodrigues M, Eeckhoutte A, et al. Germline MBD4 mutations and predisposition to uveal melanoma. J Natl Cancer Inst 2021;113:80-7.
      11.  Shields CL, Shields JA, Kiratli H, et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology 1995;102:1351–1361.
      12.  Shields CL, Cater J, Shields JA, et al. Combination of Clinical Factors Predictive of Growth of Small Choroidal Melanocytic Tumors. Arch Ophthalmol 2000;118:360–364.
      13. Shields CL, Shields JA. Clinical features of small choroidal melanoma. Curr Opin Ophthalmol 2002;13:135
      14. Shields CL, Kels JG, Shields JA. Melanoma of the eye: revealing hidden secrets, one at a time. Clin Dermatol 2015;33:183–196.
      15. Shields CL, Furuta M, Berman EL, et al. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol 2009;127:981–987.
      16.   Shields JA, Sanborn GE, Augsburger JJ. The differential diagnosis of malignant melanoma of the iris. A clinical study of 200 patients. Ophthalmology. 1983 Jun;90(6):716-20.
      17. Lewis DA, Albert DM. Chapter 138: Choroidal Nevi. In: Ryan SJ, et. al. Retina. 5th ed. Elsevier, 2013.
      18. Chapter 12: Uveal Tract. In: AAO Basic Clinical and Science Course Section 4: Ophthalmic Pathology and Intraocular Tumors. American Academy of Ophthalmology, San Francisco, 2011-2012.
      19.Cheung A, Scott IU, Murray TG, Shields CL. Distinguishing a Choroidal Nevus from a Choroidal Melanoma. Ophthalmic Pearls, EyeNet Magazine. Feb, 2012.
      20.Chapter 8: Oncology. In: Yannuzzi LA. The Retinal Atlas. Elsevier, 2010.
      21. Chapter 11: Posterior Segment. In: Trattler W, Kaiser PK, Friedman NJ. Review of Ophthalmology. 2nd. Ed. Elsevier. 2012.
      22. Collaborative Ocular Melanoma Study Group. Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular MelanomaStudy: COMS report no. 29.
      23.Singh P, Sinhg A. Choroidal melanoma. Oman J Ophthalmol. 2012 Jan-Apr; 5(1): 3–9.
      24. Wolff-Korman P, Korman B, Hazeneratz G. Duplex and color Doppler ultra­sound in the differential diagnosis of choroidal tumors. Acta Ophthalmol 1992;204:66–70. Ophthalmology. 2008 Aug;115(8):1390-7, 1397.
      25. Gunduz K, Pulido JS, Bakri SJ, et al. Fundus autofluorescence in choroidal melanocytic lesions. Retina 2007;27:681–7.
      26. Shields CL, Furuta M, Berman EL, et al. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol 2009;127:981–7.
      27. Shields CL, Kaliki S, Rojanaporn D, Ferenczy SR, Shields JA. Enhanced Depth Imaging Optical Coherence Tomography of Small Choroidal Melanoma. Arch Ophthalmol. 2012 Jul;130(7):850-6.
      28. Torres VL, Brugnoni N, Kaiser PK, et al. Optical coherence tomography enhanced depth imaging of choroidal tumors. Am J Ophthalmol 2011;151:586–93.
      29. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3. Control Clin Trials. 1993 Oct;14(5):362-91.

 30. Shields JA, Shields CL, Suvarnamani C, et al. Orbital exenteration with eyelid sparing: indications, technique, and results. Ophthalmic Surg 1991;22:292–297. 

      31. Shields JA, Shields CL, Demirci H, et al. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture. Ophthal Plast Reconstr Surg 2001;17:355–361.
      
      32.Seddon JM, Gragoudas ES, Albert DM, et al. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 1985;99:282–290.
      
      33.Shields CL, Shields JA, Karlsson U, et al. Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings. Ophthalmology 1989;96:919–23; discussion 924.
      34. Shields CL, Shields JA, Karlsson U, et al. Enucleation after Plague Radiotherapy for Posterior Uveal Melanoma: Histopathologic Findings. Ophthalmology 1990;97:1665–1670.
      35.Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119:969–982.
      36.Shields CL, Shields JA, Karlsson U, et al. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings. Ophthalmology 1990;97:1665–1670.
      37. Shields CL, Cater J, Shields JA, et al. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol 2002;120:933–940.
      38. Gündüz K, Shields CL, Shields JA, et al. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol 1999;117:170–177.
      39.Shields CL, Naseripour M, Shields JA, et al. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications. Am J Ophthalmol 2003;135:648–656.
      40.Gündüz K, Shields CL, Shields JA, et al. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am J Ophthalmol 2000;130:97–102.
      41. Gündüz K, Shields CL, Shields JA, et al. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am J Ophthalmol 2000;130:97–102.
      42.Char DH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol 1998;125:81–89.
      43. Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology 1980;87:571–581.
      44. Gragoudas ES, Lane AM, Munzenrider J, et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 2002;100:43–8; discussion 48–49.
      45. Mueller AJ, Talies S, Schaller UC, et al. Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology 2000;107:1381–7; discussion 1387–1388.
      46.Dieckmann K, Georg D, Bogner J, et al. Optimizing LINAC-based stereotactic radiotherapy of uveal melanomas: 7 years’ clinical experience. Int J Radiat Oncol Biol Phys 2006;66:S47–S52.
      47.Özcan G, Gündüz AK, Mirzayev İ, et al. Early Results of Stereotactic Radiosurgery in Uveal Melanoma and Risk Factors for Radiation Retinopathy. Turk J Ophthalmol 2020;50:156–162.
      48.van Beek JGM, van Rij CM, Baart SJ, et al. Fractionated stereotactic radiotherapy for uveal melanoma: Long-term outcome and control rates. Acta Ophthalmol. 2022;100(5):511-519. doi:10.1111/aos.15029
      49.Maheshwari A, Finger PT. Laser treatment for choroidal melanoma: Current concepts. Surv Ophthalmol. 2023;68(2):211-224. doi:10.1016/j.survophthal.2022.05.002
      50. Barbazetto IA, Lee TC, Rollins IS, et al. Treatment of choroidal melanoma using photodynamic therapy. Am J Ophthalmol 2003;135:898–899.
      51. Donaldson MJ, Lim L, Harper CA, et al. Primary treatment of choroidal amelanotic melanoma with photodynamic therapy. Clin Experiment Ophthalmol 2005;33:548–549.
Disponível em "https://ceos-stage.webservice.saude.sc.gov.br/index.php?title=Melanoma_de_coroide&oldid=52075"